News

Leveraging the robust operational data available through the Medidata Clinical Cloud, Medidata is providing metrics and analytics to help TransCelerate answer important questions posed by the industry regarding

SUGARDOWN is Boston Therapeutics’ currently marketed dietary supplement that is intended to support healthy blood sugar. In addition, clinical studies indicate that SUGARDOWN can maintain healthy glucose levels

Ceapro president and CEO Gilles Gagnon said that the signing of this Agreement is a significant milestone for our Company since this technology would allow the development, production

MDX-8704, a fixed-dosed combination (FDC) of memantine HCl extended release capsules and donepezil HCl, is being developed as a once daily therapy for the treatment of moderate-to-severe dementia

The South Korean Ministry of Food and Drug Safety (MFDS) has recently cleared Pluristem’s upgraded manufacturing process in its new facility in Haifa, Israel. The cells produced at

At present, Entyvio is approved for inducing and maintaining clinical response and remission, improving endoscopic appearance of the mucosa. The drug secured the approval to achieve corticosteroid-free remission

The ORCHARRD trial failed to meet its primary endpoint as there was no statistically significant difference in progression free survival (PFS) between the treatment arms. GSK said that

It is the first patent granted for Zestra in Canada and is valid until June 2021, while it is the tenth patent that the company’s wholly-owned subsidiary, Semprae

As part of the deal, Ophthotech will receive an immediate payment of an upfront fee of $200m plus potential future recruitment and other milestone payments. Additionally, Ophthotech is